8-KEarnings & ResultsExhibits & Filings

MICROCHIP TECHNOLOGY INC 8-K Report, Financial Results (Nov 3, 2011)

Filed November 3, 2011For Securities:MCHPMCHPP

Summary

Microchip Technology Inc. (MCHP) filed an 8-K on November 3, 2011, to announce its financial results for the second fiscal quarter ended September 30, 2011. While the 8-K itself is brief, it indicates that the detailed financial results and operational commentary are provided in an attached press release (Exhibit 99.1). Investors should refer to this press release for comprehensive information regarding the company's performance, including key financial metrics, segment performance, and management's outlook.

Key Highlights

  • 1Company announced its financial results for the second fiscal quarter of FY2012, which ended on September 30, 2011.
  • 2The detailed press release containing the financial results is attached as Exhibit 99.1 to the 8-K filing.
  • 3The filing serves as notification of the company's quarterly performance announcement.
  • 4Information provided is furnished under Item 2.02 and is not deemed 'filed' for purposes of Section 18 of the Securities Exchange Act of 1934.
  • 5Investors seeking specific financial data, operational performance, and forward-looking statements should consult the referenced press release (Exhibit 99.1).

Frequently Asked Questions

The primary purpose of this 8-K filing is to officially announce Microchip Technology Inc.'s financial results for the second fiscal quarter ended September 30, 2011, and to attach the corresponding press release containing these details.

The specific financial details, including revenue, earnings per share, and other operational metrics, are contained within the press release titled 'Microchip Technology Announces Second Quarter Fiscal Year 2012 Financial Results,' which is attached as Exhibit 99.1 to this 8-K filing.

No, the information furnished under Item 2.02 of this 8-K, including the attached press release, is being provided for informational purposes and is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This means it is not subject to the liabilities associated with that section.